158 related articles for article (PubMed ID: 12548691)
1. A chemical adaptor system designed to link a tumor-targeting device with a prodrug and an enzymatic trigger.
Gopin A; Pessah N; Shamis M; Rader C; Shabat D
Angew Chem Int Ed Engl; 2003 Jan; 42(3):327-32. PubMed ID: 12548691
[No Abstract] [Full Text] [Related]
2. New chemical adaptor unit designed to release a drug from a tumor targeting device by enzymatic triggering.
Gopin A; Rader C; Shabat D
Bioorg Med Chem; 2004 Apr; 12(8):1853-8. PubMed ID: 15051054
[TBL] [Abstract][Full Text] [Related]
3. Bioactivation of self-immolative dendritic prodrugs by catalytic antibody 38C2.
Shamis M; Lode HN; Shabat D
J Am Chem Soc; 2004 Feb; 126(6):1726-31. PubMed ID: 14871103
[TBL] [Abstract][Full Text] [Related]
4. Prodrug strategies in anticancer chemotherapy.
Kratz F; Müller IA; Ryppa C; Warnecke A
ChemMedChem; 2008 Jan; 3(1):20-53. PubMed ID: 17963208
[TBL] [Abstract][Full Text] [Related]
5. Towards bioreductively activated prodrugs: Fe(III) complexes of hydroxamic acids and the MMP inhibitor marimastat.
Failes TW; Hambley TW
J Inorg Biochem; 2007 Mar; 101(3):396-403. PubMed ID: 17197030
[TBL] [Abstract][Full Text] [Related]
6. Design of self-immolative linkers for tumour-activated prodrug therapy.
Tranoy-Opalinski I; Fernandes A; Thomas M; Gesson JP; Papot S
Anticancer Agents Med Chem; 2008 Aug; 8(6):618-37. PubMed ID: 18690826
[TBL] [Abstract][Full Text] [Related]
7. Lessons learned from marketed and investigational prodrugs.
Ettmayer P; Amidon GL; Clement B; Testa B
J Med Chem; 2004 May; 47(10):2393-404. PubMed ID: 15115379
[No Abstract] [Full Text] [Related]
8. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy.
Luo C; Sun J; Sun B; He Z
Trends Pharmacol Sci; 2014 Nov; 35(11):556-66. PubMed ID: 25441774
[TBL] [Abstract][Full Text] [Related]
9. Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progress.
Marcucci F; Lefoulon F
Drug Discov Today; 2004 Mar; 9(5):219-28. PubMed ID: 14980540
[TBL] [Abstract][Full Text] [Related]
10. Do prodrugs deliver?
Smith DA
Curr Opin Drug Discov Devel; 2007 Sep; 10(5):550-9. PubMed ID: 17786853
[TBL] [Abstract][Full Text] [Related]
11. Supramolecular drug-delivery systems based on polymeric core-shell architectures.
Haag R
Angew Chem Int Ed Engl; 2004 Jan; 43(3):278-82. PubMed ID: 14705079
[No Abstract] [Full Text] [Related]
12. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
Juillerat-Jeanneret L
Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
[TBL] [Abstract][Full Text] [Related]
13. Chemical adaptor systems.
Shabat D; Amir RJ; Gopin A; Pessah N; Shamis M
Chemistry; 2004 Jun; 10(11):2626-34. PubMed ID: 15195294
[TBL] [Abstract][Full Text] [Related]
14. Improved chemical strategies for the targeted therapy of cancer.
Maison W; Frangioni JV
Angew Chem Int Ed Engl; 2003 Oct; 42(39):4726-8. PubMed ID: 14562338
[No Abstract] [Full Text] [Related]
15. Advances in strategies to improve drug delivery to brain tumors.
Newton HB
Expert Rev Neurother; 2006 Oct; 6(10):1495-509. PubMed ID: 17078789
[TBL] [Abstract][Full Text] [Related]
16. Drug delivery systems. 2. Camptothecin 20-O-poly(ethylene glycol) ester transport forms.
Greenwald RB; Pendri A; Conover C; Gilbert C; Yang R; Xia J
J Med Chem; 1996 May; 39(10):1938-40. PubMed ID: 8642549
[No Abstract] [Full Text] [Related]
17. Prodrugs in combination with nanocarriers as a strategy for promoting antitumoral efficiency.
Lin MH; Hung CF; Hsu CY; Lin ZC; Fang JY
Future Med Chem; 2019 Aug; 11(16):2131-2150. PubMed ID: 31538520
[TBL] [Abstract][Full Text] [Related]
18. Fighting the resistance: rejuvenating anticancer platinum-based drugs.
O'Hare A
Nanomedicine (Lond); 2012 Jul; 7(7):947-8. PubMed ID: 23019670
[TBL] [Abstract][Full Text] [Related]
19. Combating the drug resistance of cisplatin using a platinum prodrug based delivery system.
Min Y; Mao CQ; Chen S; Ma G; Wang J; Liu Y
Angew Chem Int Ed Engl; 2012 Jul; 51(27):6742-7. PubMed ID: 22639083
[No Abstract] [Full Text] [Related]
20. Prodrugs--from serendipity to rational design.
Huttunen KM; Raunio H; Rautio J
Pharmacol Rev; 2011 Sep; 63(3):750-71. PubMed ID: 21737530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
